Alfonso Quintás‐Cardama

Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts

Renier J. Brentjens, Elmer Santos, Yan Nikhamin et al. · Clinical Cancer Research · 2007 · 466 citations

Medicine, Immunology, Oncology +17

Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis

Arturo Vega-Ruiz, Jörge E. Cortes, Matjaž Sever et al. · Leukemia Research · 2009 · 163 citations

Life Sciences, Immunology, Pharmacotherapy +10

Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation

Yongxing Wang, Young‐Ah Suh, Maren Y. Fuller et al. · Journal of Clinical Investigation · 2011 · 130 citations · Full text

Life Sciences, Genetics, Oncology +15

Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results

Raffit Hassan, Marcus O. Butler, Roisin E. O’Cearbhaill et al. · Nature Medicine · 2023 · 103 citations · Full text

Life Sciences, Immunology, Oncology +17

WP1066, a Novel JAK2 Inhibitor, Suppresses Proliferation and Induces Apoptosis in Erythroid Human Cells Carrying the JAK2 V617F Mutation

Srđan Verstovšek, Taghi Manshouri, Alfonso Quintás‐Cardama et al. · Clinical Cancer Research · 2008 · 83 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15